Puration, the US-based CBD infused products company, has announced the acquisition of Kaly’s Hemp4mula CBD Confections business for an undisclosed sum.
Focused on the development of a CBD formulation that can treat symptoms associated with chronic obstructive pulmonary disease and other similar respiratory conditions, Kaly is said to have patented a CBD extract that provides anti-inflammatory responses in vitro.
Hemp4mula CBD Confections is an operation own by Kaly, dedicated to the production of CBD infused gummies and gum. The company is selling its confection line to focus on its ongoing cannabis biopharmaceutical business. Puration recently launched a campaign to acquire CBD infused beverage, topical and edible operations and announced the closure of $5 million investment to fund these plans.
Similarly, the company recently acquired a CBD infused pet products operation.